A detailed history of Wells Fargo & Company transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 41,071 shares of SANA stock, worth $100,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,071
Previous 47,398 13.35%
Holding current value
$100,623
Previous $258,000 34.11%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$3.76 - $6.86 $23,789 - $43,403
-6,327 Reduced 13.35%
41,071 $170,000
Q2 2024

Aug 13, 2024

BUY
$5.23 - $10.44 $65,343 - $130,437
12,494 Added 35.8%
47,398 $258,000
Q1 2024

May 10, 2024

BUY
$4.2 - $11.27 $18,820 - $50,500
4,481 Added 14.73%
34,904 $349,000
Q4 2023

Feb 09, 2024

SELL
$2.8 - $4.55 $147,268 - $239,311
-52,596 Reduced 63.35%
30,423 $124,000
Q3 2023

Nov 13, 2023

SELL
$3.77 - $6.23 $35,860 - $59,259
-9,512 Reduced 10.28%
83,019 $321,000
Q2 2023

Aug 15, 2023

BUY
$3.22 - $7.53 $27,563 - $64,456
8,560 Added 10.19%
92,531 $551,000
Q1 2023

May 12, 2023

BUY
$3.11 - $4.92 $260,506 - $412,118
83,764 Added 40465.7%
83,971 $274,000
Q4 2022

Feb 13, 2023

SELL
$3.19 - $6.46 $9,464 - $19,166
-2,967 Reduced 93.48%
207 $0
Q3 2022

Nov 14, 2022

SELL
$5.58 - $9.04 $9,965 - $16,145
-1,786 Reduced 36.01%
3,174 $19,000
Q2 2022

Aug 12, 2022

SELL
$4.12 - $9.35 $12,508 - $28,386
-3,036 Reduced 37.97%
4,960 $32,000
Q1 2022

May 16, 2022

SELL
$5.24 - $15.58 $155,214 - $461,495
-29,621 Reduced 78.74%
7,996 $66,000
Q4 2021

Feb 14, 2022

BUY
$15.18 - $23.15 $563,754 - $859,744
37,138 Added 7753.24%
37,617 $583,000
Q3 2021

Nov 15, 2021

SELL
$16.29 - $25.88 $3,762 - $5,978
-231 Reduced 32.54%
479 $11,000
Q2 2021

Aug 16, 2021

BUY
$16.65 - $32.14 $8,191 - $15,812
492 Added 225.69%
710 $14,000
Q1 2021

May 13, 2021

BUY
$23.04 - $43.5 $5,022 - $9,483
218 New
218 $7,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $466M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.